Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for reducing early recurrence of pediatric intussusception
ChiCTR1900021390Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone in intussusception (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Early recurrence rate. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
intussusception
Beyond the preview
Go deeper on ChiCTR1900021390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021390.